IMCR Immunocore Holdings plc
Healthcare$29.41+2.01%ClosedMarket Cap: $1.49B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.72
P/S
3.80
EV/EBITDA
-508.73
DCF Value
$-245.42
FCF Yield
-2.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
98.8%
Operating Margin
-7.6%
Net Margin
-4.9%
ROE
-4.8%
ROA
-1.8%
ROIC
-3.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $106.7M | 99.6% | $7.3M | $13.0M | $— | — |
| Q4 null | $77.4M | 96.6% | $-14.6M | $-22.3M | $— | — |
| FY null | $297.6M | 97.9% | $-33.7M | $-26.4M | $— | — |
| Q3 null | $103.7M | 99.5% | $-7.2M | $785.0K | $— | — |
| Q2 null | $98.0M | 98.9% | $-14.9M | $-10.3M | $— | — |
| Q1 null | $93.9M | 99.1% | $-3.6M | $5.0M | $— | — |
| Q4 null | $84.1M | 99.6% | $-19.5M | $-23.8M | $— | — |
| FY null | $248.0M | 97.8% | $-56.3M | $-40.8M | $— | — |
| Q3 null | $80.2M | 99.4% | $-8.5M | $8.7M | $— | — |
| Q2 null | $75.4M | 97.7% | $-16.0M | $-11.6M | $— | — |
| Q1 null | $70.5M | 99.7% | $-26.5M | $-24.4M | $— | — |
| Q4 2023 | $56.0M | 99.7% | $-13.6M | $-15.7M | $-0.32 | — |